New app aims to help young diabetics get stronger and control blood sugar

NCT ID NCT07290868

First seen Jan 04, 2026

Summary

This study tests a mobile app called Diactive-1 that provides personalized resistance training and education for children and adolescents with type 1 diabetes. Over 12 weeks, participants follow a tailored exercise program (like strength training or high-intensity intervals) and track their progress. The goal is to see if the app can improve handgrip strength and help with daily diabetes management, such as insulin use.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES (T1D) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fundación Miguel Servet/ Navarrabiomed

    Pamplona, Navarre, 31008, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Diactive-1 mobile app with personalized resistance training program

What this could lead to

If successful, this app could become a standard tool to help young people with type 1 diabetes improve their fitness and better manage their condition.

What could go wrong

This is an early-stage trial with only 158 participants, so results may not apply to everyone. The app relies on user engagement, and adherence to the exercise program may be low.

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.